Greenwich LifeSciences
GLSI
#8840
Rank
โ‚น20.66 B
Marketcap
โ‚น1,408
Share price
-2.23%
Change (1 day)
92.98%
Change (1 year)

Earnings for Greenwich LifeSciences (GLSI)

Earnings in 2026 (TTM): -โ‚น2.01 Billion

According to Greenwich LifeSciences's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น1.76 Billion a decrease over its 2024 earnings that were of -โ‚น1.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Greenwich LifeSciences from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น2.01 Billion13.82%
2025 -โ‚น1.76 Billion16.52%
2024 -โ‚น1.51 Billion71.66%
2023 -โ‚น0.88 Billion16.01%
2022 -โ‚น0.76 Billion74.87%
2021 -โ‚น0.44 Billion146.7%
2020 -โ‚น0.18 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-โ‚น0.24 Billion-88.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-โ‚น6.89 Billion 234.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น21.06 Billion 921.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-โ‚น8.48 Billion 311.39% Jersey